ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1200506
CHEMBL1200506
Compound Name ERYTHROMYCIN LACTOBIONATE
ChEMBL Synonyms ERYTHROCIN | ERYTHROMYCIN | ERYTHROMYCIN LACTOBIONATE
Max Phase 4 (Approved)
Trade Names ERYTHROCIN | ERYTHROMYCIN | ERYTHROMYCIN LACTOBIONATE
Molecular Formula C49H89NO25

Additional synonyms for CHEMBL1200506 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C ...
Download SMILES
Standard InChI InChI=1S/C37H67NO13.C12H22O12/c1-14-25-37(10,45)30(41)20(4)2 ...
Download InChI
Standard InChI Key NNRXCKZMQLFUPL-WBMZRJHASA-N

Sources

  • British National Formulary
  • Curated Drug Metabolism Pathways
  • HeCaToS Compounds
  • Orange Book
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names

Alternate Forms of Compound in ChEMBL


CHEMBL1200506

Molecule Features

CHEMBL1200506 compound icon
Drug Type:Natural Product-derived Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Bacterial 70S ribosome inhibitor Bacterial 70S ribosome DailyMed PubMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Diabetes Mellitus, Type 1D003922EFO:0001359type I diabetes mellitus1ClinicalTrials
OsteomyelitisD010019EFO:0003102osteomyelitis0ClinicalTrials
ClinicalTrials

Clinical Data

ClinicalTrials.gov ERYTHROMYCIN LACTOBIONATE
The Cochrane Collaboration ERYTHROMYCIN LACTOBIONATE

Metabolites for CHEMBL1200506

Open in full screen

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
733.9 733.4612 1.79 7 193.91 NEUTRAL


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
14 5 2 14 5 2


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
13.09 8.16 1.91 1.16 0 51 0.24

Structural Alerts

There are 3 structural alerts for CHEMBL1200506. To view alerts please click here.

Compound Cross References

ChemSpider ChemSpider:NNRXCKZMQLFUPL-WBMZRJHASA-N
DailyMed erythromycin lactobionate

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL1200506



ACToR 1334-29-8 3847-29-8 1334-39-0
FDA SRS 33H58I7GLQ
MolPort MolPort-006-115-742
PubChem 71469
SureChEMBL SCHEMBL41566

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/NNRXCKZMQLFUPL-WBMZRJHASA-N spacer
spacer